Base de dados : MEDLINE
Pesquisa : C11.338.133 [Categoria DeCS]
Referências encontradas : 1130 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 113 ir para página                         

  1 / 1130 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28888529
[Au] Autor:Devambez H; Richeux M; Guericolas M; Choquet C; Casalino E; Ghazali AD
[Ad] Endereço:Emergency Department, University Hospital of Bichat, AP-HP, Paris, France.
[Ti] Título:Eyelid inflammation: An uncommon cause in occidental countries.
[So] Source:Am J Emerg Med;35(11):1789.e3-1789.e5, 2017 Nov.
[Is] ISSN:1532-8171
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Myiasis designates the infestation of live human and vertebrate animals with dipterous (two-winged) larvae (maggots) and is the fourth most common travel-associated skin disease. Furuncle is the most common aspect of cutaneous myiasis. CASE PRESENTATION: A 24-year-old Caucasian female had been back from Cap-Vert. She described pruritus, slight pain, and the sensation of a foreign body moving in the eyelid. Physical examination showed a single furuncle-like nodule with surrounding erythema and a central pore of the upper eyelid through which a serosanguinous fluid was exuding. A larval end was visible to the naked eye through the aforementioned pore. Treatment consisted of the application of petroleum jelly (Vaseline®) to produce localized hypoxia. A transparent occlusive dressing was set for a duration of 2 h. The larva, Cordylobia antropophaga, spontaneously externalized to breathe and was extracted. DISCUSSION: There is an increase in travelers returning from tropical countries. Consequently, travel-associated dermatoses are increasing in non-endemic countries. Context of travel and typical clinical presentation strongly suggested to evoke a cutaneous myiasis. The typical furuncular lesion is a papule or nodule with a central punctum that exudes serosanguinous or purulent fluid. Ultrasound can be used to confirm the diagnosis. Treatment consists of three techniques: methods producing localized hypoxia to force emergence of the larvae, application of toxic substances to the eggs and larvae, and mechanical or surgical debridement. Surgery and antibiotics are usually unnecessary. Prevention of furunculous myiasis is based on vector control and individual actions to improve hygiene.
[Mh] Termos MeSH primário: Blefarite/diagnóstico
Miíase/diagnóstico
Curativos Oclusivos
Vaselina
Viagem
[Mh] Termos MeSH secundário: Blefarite/terapia
Serviço Hospitalar de Emergência
Feminino
França
Seres Humanos
Miíase/terapia
Senegal
Adulto Jovem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
8009-03-8 (Petrolatum)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171106
[Lr] Data última revisão:
171106
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170911
[St] Status:MEDLINE


  2 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28696955
[Au] Autor:Rousta ST
[Ad] Endereço:aDivision of Pediatric Ophthalmology, Robert Wood Johnson Medical School, New Brunswick, New Jersey bWills Eye Hospital, Philadelphia, Pennsylvania, USA.
[Ti] Título:Pediatric blepharokeratoconjunctivitis: is there a 'right' treatment?
[So] Source:Curr Opin Ophthalmol;28(5):449-453, 2017 Sep.
[Is] ISSN:1531-7021
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE OF REVIEW: This article highlights the importance of recognizing blepharokeratoconjunctivitis (BKC) in children and reviews the clinical characteristics and current therapeutic modalities. RECENT FINDINGS: The mainstay of BKC treatment remains controlling the meibomian gland inflammation and treating cobormid conditions. BKC can occur in the setting of ocular rosacea and Demodex infestation. Small studies have shown treatment benefits of topical cyclosporine A as well as oral azithromycin in pediatric BKC. SUMMARY: BKC is a cause for visual loss in children, and therefore pediatric ophthalmologists should be more vigilant about early diagnosis and long-term treatment. There is a lack of randomized controlled trials on this topic and no standardized outcome measures. Better ways to measure the clinical outcome of various treatment modalities need to be developed.
[Mh] Termos MeSH primário: Antibacterianos/administração & dosagem
Blefarite/tratamento farmacológico
Diagnóstico Precoce
Ceratoconjuntivite/tratamento farmacológico
[Mh] Termos MeSH secundário: Blefarite/diagnóstico
Criança
Seres Humanos
Ceratoconjuntivite/diagnóstico
Soluções Oftálmicas
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Ophthalmic Solutions)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170901
[Lr] Data última revisão:
170901
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170712
[St] Status:MEDLINE
[do] DOI:10.1097/ICU.0000000000000399


  3 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28372717
[Au] Autor:Tarff A; Behrens A
[Ad] Endereço:The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 North Broadway, Suite 4001, Baltimore, MD 21231, USA.
[Ti] Título:Ocular Emergencies: Red Eye.
[So] Source:Med Clin North Am;101(3):615-639, 2017 May.
[Is] ISSN:1557-9859
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:"Red eye" is used as a general term to describe irritated or bloodshot eyes. It is a recognizable sign of an acute/chronic, localized/systemic underlying inflammatory condition. Conjunctival injection is most commonly caused by dryness, allergy, visual fatigue, contact lens overwear, and local infections. In some instances, red eye can represent a true ocular emergency that should be treated by an ophthalmologist. A comprehensive assessment of red eye conditions is required to preserve the patients visual function. Severe ocular pain, significant photophobia, decreased vision, and history of ocular trauma are warning signs demanding immediate ophthalmological consultation.
[Mh] Termos MeSH primário: Emergências
Oftalmopatias/fisiopatologia
Oftalmopatias/terapia
[Mh] Termos MeSH secundário: Blefarite/fisiopatologia
Blefarite/terapia
Conjuntivite/diagnóstico
Conjuntivite/fisiopatologia
Lesões da Córnea/terapia
Síndromes do Olho Seco/tratamento farmacológico
Síndromes do Olho Seco/fisiopatologia
Endoftalmite/fisiopatologia
Endoftalmite/terapia
Oftalmopatias/diagnóstico
Corpos Estranhos no Olho/terapia
Glaucoma de Ângulo Fechado/fisiopatologia
Glaucoma de Ângulo Fechado/terapia
Hemorragia/fisiopatologia
Hemorragia/terapia
Seres Humanos
Inflamação
Ceratite/diagnóstico
Ceratite/fisiopatologia
Esclerite/fisiopatologia
Esclerite/terapia
Uveíte/fisiopatologia
Uveíte/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170424
[Lr] Data última revisão:
170424
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170405
[St] Status:MEDLINE


  4 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28257379
[Au] Autor:OʼSullivan R; Tom LM; Bunya VY; Nyberg WC; Massaro-Giordano M; Daniel E; Smith E; Brainard DH; Gee J; Maguire MG; Stone RA
[Ad] Endereço:*Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA; ‡Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA; Departments of §Psychology; and ¶Radiology, University of Pennsylvania, Philadelphia, PA.
[Ti] Título:Use of Crossed Polarizers to Enhance Images of the Eyelids.
[So] Source:Cornea;36(5):631-635, 2017 May.
[Is] ISSN:1536-4798
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: To describe imaging of the external eye with Crossed Polarizers to enhance clinically important features in digital photographs of the eyelids. METHODS: External photographs with and without crossed polarizing filters were taken of patients with blepharitis and controls with no clinical eye pathology. RESULTS: Photographing eyelid skin through Crossed Polarizers decreased reflections on the skin surface and improved visualization of eyelid telangiectasias and blood vessels in patients with a broad range of skin pigmentation and ethnicities. CONCLUSIONS: The use of Crossed Polarizers in imaging the external eye reduces reflections and glare from the eyelid skin and margins, thereby allowing for a more detailed evaluation of underlying structures and analysis of images. These findings suggest that including Crossed Polarizers in clinical photography has informative applications for assessing eyelid disease.
[Mh] Termos MeSH primário: Blefarite/diagnóstico por imagem
Técnicas de Diagnóstico Oftalmológico
Fotografia/métodos
[Mh] Termos MeSH secundário: Estudos de Casos e Controles
Túnica Conjuntiva/diagnóstico por imagem
Córnea/diagnóstico por imagem
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170929
[Lr] Data última revisão:
170929
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170304
[St] Status:MEDLINE
[do] DOI:10.1097/ICO.0000000000001157


  5 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28183148
[Au] Autor:Rim TH; Kang MJ; Choi M; Seo KY; Kim SS
[Ad] Endereço:Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.
[Ti] Título:Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study.
[So] Source:Clin Exp Ophthalmol;45(5):448-454, 2017 Jul.
[Is] ISSN:1442-9071
[Cp] País de publicação:Australia
[La] Idioma:eng
[Ab] Resumo:IMPORTANCE: Blepharitis is one of the most common conditions. However, no study has yet evaluated the epidemiology by evaluating a large population-based sample. BACKGROUND: To evaluate the incidence and prevalence of clinically diagnosed blepharitis in South Korea. DESIGN: Nationwide population-based study. PARTICIPANTS: We investigated the Korean National Health Insurance Service-National Sample Cohort, a representative one million-sample of the Korean population, for patients diagnosed with blepharitis according to the Korean Classification of Diseases. METHODS: Annual and overall incidence and prevalence of blepharitis during the study period (2004-2013) were estimated after excluding chronic blepharitis patients, diagnosed during 2002-2003. Sociodemographic factors and comorbidities associated with blepharitis were evaluated using Cox proportional hazard regression. MAIN OUTCOME MEASURES: The first occurrence of blepharitis. RESULTS: A total of 1 116 363 individuals over 9 698 118 person-years were evaluated (mean follow up: 8.7 years) from 2004 to 2013. The overall incidence was 1.1 (95% confidence interval, 1.1-1.1) per 100 person-years. The incidence increased with time (0.9 vs. 1.3 per 100 person-years, in 2004 and 2013, respectively) and was higher in female patients (1.3 vs. 0.9 per 100 person-years, respectively). The overall prevalence was 8.1% (95% confidence interval: 8.0-8.1) among subjects aged 40 years or older. Chalazion, gastritis, Sjögren's syndrome, pterygium, rosacea, prostatic hypertrophy, atopy, irritable bowel disease and peptic ulcer were associated with an increased incidence of blepharitis in the multivariable Cox model. CONCLUSIONS: We found that blepharitis was a relatively common disease and is associated with various ocular and systemic conditions.
[Mh] Termos MeSH primário: Blefarite/epidemiologia
Previsões
Vigilância da População/métodos
Sistema de Registros
[Mh] Termos MeSH secundário: Adolescente
Adulto
Distribuição por Idade
Idoso
Idoso de 80 Anos ou mais
Blefarite/diagnóstico
Criança
Pré-Escolar
Feminino
Seguimentos
Seres Humanos
Incidência
Lactente
Recém-Nascido
Masculino
Meia-Idade
Prevalência
República da Coreia/epidemiologia
Estudos Retrospectivos
Fatores de Risco
Distribuição por Sexo
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171102
[Lr] Data última revisão:
171102
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170210
[St] Status:MEDLINE
[do] DOI:10.1111/ceo.12929


  6 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:28170093
[Au] Autor:O'Gallagher M; Bunce C; Hingorani M; Larkin F; Tuft S; Dahlmann-Noor A
[Ad] Endereço:Moorfields Eye Hospital NHS Foundation Trust, 162 City Road, London, UK, EC1V 2PD.
[Ti] Título:Topical treatments for blepharokeratoconjunctivitis in children.
[So] Source:Cochrane Database Syst Rev;2:CD011965, 2017 02 07.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Blepharokeratoconjunctivitis (BKC) is a type of inflammation of the surface of the eye and eyelids that involves changes of the eyelids, dysfunction of the meibomian glands, and inflammation of the conjunctiva and cornea. Chronic inflammation of the cornea can lead to scarring, vascularisation and opacity. BKC in children can cause significant symptoms including irritation, watering, photophobia and loss of vision from corneal opacity, refractive error or amblyopia.Treatment of BKC is directed towards modification of meibomian gland disease and the bacterial flora of lid margin and conjunctiva, and control of ocular surface inflammation. Although both topical and systemic treatments are used to treat people with BKC, this Cochrane review focuses on topical treatments. OBJECTIVES: To assess and compare data on the efficacy and safety of topical treatments (including antibiotics, steroids, immunosuppressants and lubricants), alone or in combination, for BKC in children from birth to 16 years. SEARCH METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 6), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE ( January 1946 to 11 July 2016), Embase (January 1980 to 11 July 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 11 July 2016. We searched the reference lists of identified reports and the Science Citation Index to identify any additional reports of studies that met the inclusion criteria. SELECTION CRITERIA: We searched for randomised controlled trials that involved topical treatments in children up to 16 years of age with a clinical diagnosis of BKC. We planned to include studies that evaluated a single topical medication versus placebo, a combination of treatments versus placebo, and those that compared two or multiple active treatments. We planned to include studies in which participants received additional treatments, such as oral antibiotics, oral anti-inflammatories, warm lid compresses and lid margin cleaning. DATA COLLECTION AND ANALYSIS: Two review authors independently screened the results of the literature search (titles and abstracts) to identify studies that met the inclusion criteria of the review and applied standards as expected for Cochrane reviews. We graded the certainty of the evidence using GRADE. MAIN RESULTS: We included one study from the USA that met the inclusion criteria. In the study, 137 children aged zero to six years old with blepharoconjunctivitis were randomised to treatment in one of four trial arms (loteprednol etabonate/tobramycin combination, loteprednol etabonate alone, tobramycin alone or placebo) for 15 days, with assessments on days 1, 3, 7 and 15. We judged the study to be at high risk of attrition bias and bias due to selective outcome reporting. The study did not report the number of children with improvement in symptoms nor with total or partial success as measured by changes in clinical symptoms.All children showed a reduction in blepharoconjunctivitis grade score, but there was no evidence of important differences between groups. Visual acuity was not fully reported but the authors stated that there was no change in visual acuity in any of the treatment groups. The study reported ocular and non ocular adverse events but was underpowered to detect differences between the groups. Ocular adverse events were as follows: loteprednol/tobramycin 1/34 (eye pain); loteprednol 4/35 (eye pain, conjunctivitis, eye discharge, eye inflammation); tobramycin 0/34; placebo (vehicle) 0/34. The evidence was limited for all these outcomes and we judged it to be very low certainty.There was no information on clinical signs (aside from grade score), disease progression or quality of life. AUTHORS' CONCLUSIONS: There is no high-quality evidence of the safety and efficacy of topical treatments for BKC, which resulted in uncertainty about the indications and effectiveness of topical treatment. Clinical trials are required to test efficacy and safety of current and any future treatments. Outcome measures need to be developed which can capture both objective clinical and patient-reported aspects of the condition and treatments.
[Mh] Termos MeSH primário: Antialérgicos/administração & dosagem
Antibacterianos/administração & dosagem
Blefarite/tratamento farmacológico
Ceratoconjuntivite/tratamento farmacológico
Etabonato de Loteprednol/administração & dosagem
Tobramicina/administração & dosagem
[Mh] Termos MeSH secundário: Administração Tópica
Antialérgicos/efeitos adversos
Antibacterianos/efeitos adversos
Criança
Pré-Escolar
Túnica Conjuntiva/microbiologia
Pálpebras/microbiologia
Seres Humanos
Lactente
Recém-Nascido
Ensaios Clínicos Controlados Aleatórios como Assunto
Tobramicina/efeitos adversos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Nm] Nome de substância:
0 (Anti-Allergic Agents); 0 (Anti-Bacterial Agents); VZ8RRZ51VK (Tobramycin); YEH1EZ96K6 (Loteprednol Etabonate)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170619
[Lr] Data última revisão:
170619
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170208
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD011965.pub2


  7 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28135754
[Au] Autor:Giers JC; Halstenberg S; Voßmerbäumer U; Pitz S
[Ad] Endereço:Augenklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
[Ti] Título:[Alternative Methods of Local Therapy for Complicated Periocular Infections - Two Case Reports].
[Ti] Título:Alternative Methoden der Lokaltherapie bei komplizierten periokulären Infektionen ­ 2 Fallberichte..
[So] Source:Klin Monbl Augenheilkd;234(1):36-39, 2017 Jan.
[Is] ISSN:1439-3999
[Cp] País de publicação:Germany
[La] Idioma:ger
[Ab] Resumo:Wounds of the eyelid can usually be cured with common surgical measures and the use of local antibiotics. Here we present two cases to demonstrate that biological debridement and negative pressure vacuum therapy (NPWT), two second line therapies, are effective and possibly superior alternatives to conventional, antibiotic-based approaches. A persistent infectious wound of the upper eyelid after surgical debridement of necrotising fasciitis and an upper eyelid abscess with multiple purulent entry points, which was refractory to a five-week antibiotic regimen, were treated with biological debridement and NPWT. The combination of these two therapies leads to an optimal outcome. Our cases demonstrate that, in ophthalmology, uncommon methods such as biological debridement and NPWT are quite practicable and are valuable therapeutic options.
[Mh] Termos MeSH primário: Blefarite/terapia
Desbridamento/métodos
Infecções Oculares/terapia
Tratamento de Ferimentos com Pressão Negativa/métodos
Infecção da Ferida Cirúrgica/terapia
[Mh] Termos MeSH secundário: Adulto
Blefarite/diagnóstico
Terapia Combinada
Infecções Oculares/diagnóstico
Feminino
Seres Humanos
Masculino
Infecção da Ferida Cirúrgica/diagnóstico
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170828
[Lr] Data última revisão:
170828
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170131
[St] Status:MEDLINE
[do] DOI:10.1055/s-0042-121807


  8 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28135744
[Au] Autor:Roth M; Holtmann C; Kajasi N; Lanzman RS; MacKenzie CR; Geerling G; Borrelli M
[Ad] Endereço:Augenklinik, Universitätsklinikum Düsseldorf.
[Ti] Título:[Peri-ocular Necrotising Fasciitis - Case Report and Overview].
[Ti] Título:Periokuläre nekrotisierende Fasziitis ­ Fallbericht und Überblick..
[So] Source:Klin Monbl Augenheilkd;234(1):40-45, 2017 Jan.
[Is] ISSN:1439-3999
[Cp] País de publicação:Germany
[La] Idioma:ger
[Ab] Resumo:Peri-ocular necrotising fasciitis is a very rare ophthalmological clinical picture and is potentially fatal. This disease is caused by bacterial infection of the fasciae, which rapidly spreads. The present article reports a typical case of the disease and gives an overview of the typical clinical signs and symptoms of peri-ocular necrotising fasciitis.
[Mh] Termos MeSH primário: Blefarite/terapia
Infecções Oculares Bacterianas/terapia
Fasciite Necrosante/terapia
Doenças Orbitárias/terapia
[Mh] Termos MeSH secundário: Idoso de 80 Anos ou mais
Antibacterianos/uso terapêutico
Blefarite/diagnóstico
Terapia Combinada/métodos
Desbridamento/métodos
Infecções Oculares Bacterianas/diagnóstico
Fasciite Necrosante/diagnóstico
Feminino
Seres Humanos
Doenças Orbitárias/diagnóstico
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170828
[Lr] Data última revisão:
170828
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170131
[St] Status:MEDLINE
[do] DOI:10.1055/s-0042-119300


  9 / 1130 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28109687
[Au] Autor:Moyal L; Adam R; Akesbi J; Rodallec FT; Nordmann JP
[Ad] Endereço:Service d'ophtalmologie II, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France. Electronic address: lauramoyal@yahoo.fr.
[Ti] Título:[Ocular graft-versus-host disease: An often misdiagnosed etiology of dry eye syndrome].
[Ti] Título:Réaction oculaire du greffon contre l'hôte : une étiologie de syndrome sec à ne pas méconnaître..
[So] Source:J Fr Ophtalmol;40(2):122-125, 2017 Feb.
[Is] ISSN:1773-0597
[Cp] País de publicação:France
[La] Idioma:fre
[Ab] Resumo:PURPOSE: To report a case of severe ocular graft-versus-host disease (GVHD) after cataract surgery. METHODS: Observational case report. RESULTS: We describe the case of a 59-year-old man with postoperative corneal ulcer on his only functional eye. His past history reported allogenic bone marrow transplant. His visual acuity (VA) was limited to hand motions. Slit lamp examination revealed diffuse conjunctival hyperemia, severe blepharitis, Meibomian dysfunction, total corneal opacification with epithelial and stromal keratitis and neovascular invasion. Because of the severe dry eye symptoms and history of allogenic hematological stem cell transplantation, ocular GVHD was diagnosed. Functional and anatomical improvement occurred rapidly with topical cyclosporine 2%, with improved VA after treatment. CONCLUSION: With any severe dry eye syndrome in the context of allogenic bone marrow transplant, ocular GVHD must be considered. For planned ocular surgery, we recommend adding cyclosporine 0.1% treatment before and after surgery to prevent severe ocular GVHD.
[Mh] Termos MeSH primário: Blefarite/diagnóstico
Blefarite/etiologia
Síndromes do Olho Seco/diagnóstico
Síndromes do Olho Seco/etiologia
Doença Enxerto-Hospedeiro/complicações
Doença Enxerto-Hospedeiro/diagnóstico
[Mh] Termos MeSH secundário: Blefarite/tratamento farmacológico
Ciclosporina/uso terapêutico
Erros de Diagnóstico
Síndromes do Olho Seco/tratamento farmacológico
Doença Enxerto-Hospedeiro/tratamento farmacológico
Doença Enxerto-Hospedeiro/patologia
Seres Humanos
Masculino
Meia-Idade
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
83HN0GTJ6D (Cyclosporine)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170926
[Lr] Data última revisão:
170926
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170123
[St] Status:MEDLINE


  10 / 1130 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28099212
[Au] Autor:Milner MS; Beckman KA; Luchs JI; Allen QB; Awdeh RM; Berdahl J; Boland TS; Buznego C; Gira JP; Goldberg DF; Goldman D; Goyal RK; Jackson MA; Katz J; Kim T; Majmudar PA; Malhotra RP; McDonald MB; Rajpal RK; Raviv T; Rowen S; Shamie N; Solomon JD; Stonecipher K; Tauber S; Trattler W; Walter KA; Waring GO; Weinstock RJ; Wiley WF; Yeu E
[Ad] Endereço:aYale University School of Medicine, New Haven bThe Eye Center of Southern Connecticut, Hamden, Connecticut cOhio State University, Columbus dComprehensive Eye Care of Central Ohio, Westerville, Ohio eHofstra Northwell School of Medicine, Hempstead fSouth Shore Eye Care, Wantagh, New York gFlorida Vision Institute, Jupiter hBascom Palmer Eye Institute, Florida International University, and Center for Excellence in Eye Care, Miami, Florida iVance Thompson Vision, Sioux Falls, South Dakota jNortheastern Eye Institute, Scranton kCommonwealth Medical College, Scranton, Pennsylvania lOphthalmology Consultants, St. Louis, Missouri mJules Stein Eye Institute, Los Angeles nWolstan & Goldberg Eye Associates, Torrance, California oPalm Beach Gardens, Florida pRush University Medical Center, Chicago qChicago Eye Specialists rUniversity of Chicago Hospitals, Chicago sJacksoneye, Lake Villa tMidwest Center for Sight, Des Plaines, Illinois uDuke Eye Center, Durham, North Carolina vChicago Cornea Consultants, Ltd, Hoffman Estates, Illinois wWashington University Department of Ophthalmology and Ophthalmology Associates, St. Louis, Missouri xNYU Langone Medical Center, New York, New York yTulane University School of Medicine, New Orleans, Louisiana zOphthalmic Consultants of Long Island, Lynbrook, New York aaThe Center for Ocular Surface Excellence of New Jersey, Woodland Park, New Jersey bbGeorgetown University Medical Center, George Washington University Medical Center, Washington, DC ccNew York Eye and Ear Infirmary of Mount Sinai and Eye Center of New York, New York, New York ddNVision EyeCenters of Newport Beach, Newport Beach, California eeUniversity of Maryland, Baltimore, Maryland ffAdvanced Vision Care, Century City, California ggKeck School of Medicine, University of Southern California, Los Angeles hhBowie Vision Institute, Bowie, Maryland iiUniversity of North Carolina and TLC Laser Eye Centers, Greensboro, North Carolina jjMercy Eye Specialists, Springfield, Missouri kkWake Forest University, Winston-Salem, North Carolina llStorm Eye Institute and Magill Vision Center, Medical University of South Carolina, Charleston mmClemson University, Mt. Pleasant, South Carolina nnUniversity of South Florida, Tampa ooThe Eye Institute of West Florida, Largo, Florida ppCleveland Eye Clinic, Clear Choice Custom LASIK Center, Brecksville, Ohio qqEastern Virginia Medical School and Virginia Eye Consultants, Norfolk, Virginia, USA *Mark S. Milner, Kenneth A. Beckman, and Jodi I. Luchs are co-chairs.
[Ti] Título:Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.
[So] Source:Curr Opin Ophthalmol;27 Suppl 1:3-47, 2017 Jan.
[Is] ISSN:1531-7021
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Dysfunctional tear syndrome (DTS) is a common and complex condition affecting the ocular surface. The health and normal functioning of the ocular surface is dependent on a stable and sufficient tear film. Clinician awareness of conditions affecting the ocular surface has increased in recent years because of expanded research and the publication of diagnosis and treatment guidelines pertaining to disorders resulting in DTS, including the Delphi panel treatment recommendations for DTS (2006), the International Dry Eye Workshop (DEWS) (2007), the Meibomian Gland Dysfunction (MGD) Workshop (2011), and the updated Preferred Practice Pattern guidelines from the American Academy of Ophthalmology pertaining to dry eye and blepharitis (2013). Since the publication of the existing guidelines, new diagnostic techniques and treatment options that provide an opportunity for better management of patients have become available. Clinicians are now able to access a wealth of information that can help them obtain a differential diagnosis and treatment approach for patients presenting with DTS. This review provides a practical and directed approach to the diagnosis and treatment of patients with DTS, emphasizing treatment that is tailored to the specific disease subtype as well as the severity of the condition.
[Mh] Termos MeSH primário: Síndromes do Olho Seco
Doenças Palpebrais/fisiopatologia
Glândulas Tarsais/fisiopatologia
Lágrimas/fisiologia
[Mh] Termos MeSH secundário: Blefarite/diagnóstico
Blefarite/fisiopatologia
Blefarite/terapia
Síndromes do Olho Seco/diagnóstico
Síndromes do Olho Seco/fisiopatologia
Síndromes do Olho Seco/terapia
Seres Humanos
Ceratoconjuntivite Seca/diagnóstico
Ceratoconjuntivite Seca/fisiopatologia
Ceratoconjuntivite Seca/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170119
[St] Status:MEDLINE
[do] DOI:10.1097/01.icu.0000512373.81749.b7



página 1 de 113 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde